Dr. Kathleen MacLellan:

I will respond to that. The allowable costs are related to the current guidance in place, and antigen testing currently is not recommended for use in nursing homes. With regard to the recent visiting guidance, significant research and examination by AMRIC and the HPSC were conducted on the use of antigen testing and the available international evidence. It is being kept under review. Should the guidance change, obviously eligible costs under TAPS will be considered, but at present the eligible costs under TAPS are aligned to the guidance that is available.

My colleague, Mr. Redmond, might wish to add to that.